1. Phase I/II study of bendamustine in combination with ofatumumab, carboplatin, etoposide (BOCE) for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma. Issue 3 (23rd February 2021) Authors: Pan, Jonathan; Ghimire, Sushil; Alpdogan, S. Onder; Chapman, Andrew; Carabasi, Matthew; DiMeglio, Martina; Gong, Jerald; Martinez-Outschoorn, Ubaldo; Rose, Lewis; Ramirez, Michael; Wagner, John L.; Weiss, Mark; Flomenberg, Neal; Pro, Barbara; Porcu, Pierluigi; Filicko-OHara, Joanne; Gaballa, Sameh Journal: Leukemia & lymphoma Issue: Volume 62:Issue 3(2021) Page Start: 590 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗